Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FC45E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,823
Award facts
- Contract value 100% obligated
- $26,823.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,823 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Wegovy (semaglutide) 1 mg/0.5 mL pen injections, with performance at the contractor's Conshohocken, Pennsylvania facility. The award, issued on July 14, 2025, represents a competitive procurement with no set-aside designation and a completion date of July 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply vehicle valued through December 2026 that enables the company to furnish a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor headquartered in Pennsylvania, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering both brand-name and generic pharmaceuticals, vaccines, and specialized medical commodities across multiple therapeutic domains. This delivery order for Wegovy reflects the contractor's established capability to supply specialty medications to military and defense healthcare operations, consistent with the DLA's strategy of maintaining multiple qualified pharmaceutical vendors for regional support under the planned Pharmaceutical Prime Vendor Global Program Generation V initiative.
Quick answers
Who was awarded contract SPE2DB25FC45E?
SPE2DB25FC45E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FC45E worth?
The government has obligated $26,823 on SPE2DB25FC45E.
Is contract SPE2DB25FC45E an order under another contract?
Yes. SPE2DB25FC45E is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FC45E competed?
The extent of competition for SPE2DB25FC45E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award